154 related articles for article (PubMed ID: 18618076)
1. Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.
Arena V; Skanjeti A; Casoni R; Douroukas A; Pelosi E
Radiol Med; 2008 Sep; 113(6):875-86. PubMed ID: 18618076
[TBL] [Abstract][Full Text] [Related]
2. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
[TBL] [Abstract][Full Text] [Related]
3. Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.
Tahari AK; Lodge MA; Wahl RL
J Med Imaging Radiat Oncol; 2014; 58(3):277-82. PubMed ID: 24438486
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of PET image reconstruction using a spatial resolution model.
Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
[TBL] [Abstract][Full Text] [Related]
5. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
6. Dual-time-point FDG-PET/CT for the detection of hepatic metastases.
Dirisamer A; Halpern BS; Schima W; Heinisch M; Wolf F; Beheshti M; Dirisamer F; Weber M; Langsteger W
Mol Imaging Biol; 2008; 10(6):335-40. PubMed ID: 18709509
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
9. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
10. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H
Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of total-body
Hu Y; Liu G; Yu H; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
[TBL] [Abstract][Full Text] [Related]
12. Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma.
Lin WY; Tsai SC; Hung GU
Nucl Med Commun; 2005 Apr; 26(4):315-21. PubMed ID: 15753790
[TBL] [Abstract][Full Text] [Related]
13. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
15. Impact of acquisition geometry, image processing, and patient size on lesion detection in whole-body 18F-FDG PET.
El Fakhri G; Santos PA; Badawi RD; Holdsworth CH; Van Den Abbeele AD; Kijewski MF
J Nucl Med; 2007 Dec; 48(12):1951-60. PubMed ID: 18006613
[TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Veit-Haibach P; Treyer V; Strobel K; Soyka JD; Husmann L; Schaefer NG; Tschopp A; Hany TF
Abdom Imaging; 2010 Oct; 35(5):528-36. PubMed ID: 19593563
[TBL] [Abstract][Full Text] [Related]
18. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
19. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
20. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
